JHU Institute for Cell Engineering (ICE)

The Institute for Cell Engineering (ICE) at Johns Hopkins University School of Medicine is at the forefront of innovative research aimed at harnessing the potential of stem cells to enhance human health. This distinguished clinic brings together a multidisciplinary team of researchers, including faculty, fellows, postdocs, and students, who are dedicated to tackling some of the most pressing challenges in modern medicine. The institute's primary focus encompasses four key research programs: Immunobiology, Neuroregeneration, Stem Cell Biology, and Vascular Biology, each aimed at addressing a wide array of conditions such as Parkinson's disease, ALS, cancer, diabetes, heart failure, stroke, and spinal cord injury. ICE is committed to accelerating the transition of groundbreaking scientific discoveries into clinical applications, therefore offering a unique value proposition in the realm of anti-aging and longevity medicine. They strive to develop new cell-based therapies that could revolutionize treatment options for various diseases. With an emphasis on collaboration and innovation, the clinic is equipped with advanced research facilities and a wealth of expertise, making it a pivotal player in the quest for improved health outcomes. This commitment to excellence not only positions ICE as a leader in cell engineering but also as a vital contributor to the future of regenerative medicine and longevity.